161 related articles for article (PubMed ID: 21989120)
1. Comparison of various strategies for colorectal cancer screening tests.
Wohl P; Bednařík M; Wohl P; Cervenka M; Spičák J
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1157-64. PubMed ID: 21989120
[TBL] [Abstract][Full Text] [Related]
2. Screening based on risk for colorectal cancer is the most cost-effective approach.
Dan YY; Chuah BY; Koh DC; Yeoh KG
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):266-71.e1-6. PubMed ID: 22100624
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.
Hassan C; Zullo A; Winn S; Morini S
Endoscopy; 2008 May; 40(5):414-21. PubMed ID: 18302080
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness and projected national impact of colorectal cancer screening in France.
Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
[TBL] [Abstract][Full Text] [Related]
5. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
6. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
[TBL] [Abstract][Full Text] [Related]
7. Evidence for colorectal cancer screening.
Bretthauer M
Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):417-25. PubMed ID: 20833346
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
9. A population-based estimate of the extent of colorectal cancer screening in Ontario.
Rabeneck L; Paszat LF
Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
[TBL] [Abstract][Full Text] [Related]
10. A simulation model for colorectal cancer screening: potential of stool tests with various performance characteristics compared with screening colonoscopy.
Haug U; Brenner H
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):422-8. PubMed ID: 15734968
[TBL] [Abstract][Full Text] [Related]
11. Is PillCam COLON capsule endoscopy ready for colorectal cancer screening? A prospective feasibility study in a community gastroenterology practice.
Sieg A; Friedrich K; Sieg U
Am J Gastroenterol; 2009 Apr; 104(4):848-54. PubMed ID: 19240710
[TBL] [Abstract][Full Text] [Related]
12. Impact of technology overlapping: a case study on colorectal cancer screening.
Di Bidino R; Cicchetti A; Corio M; Polisena J; Oradei M; Marchetti M
Technol Health Care; 2010; 18(4-5):303-15. PubMed ID: 21209479
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a selective screening for colorectal carcinoma: the Taiwan Multicenter Cancer Screening (TAMCAS) project.
Chen TH; Yen MF; Lai MS; Koong SL; Wang CY; Wong JM; Prevost TC; Duffy SW
Cancer; 1999 Oct; 86(7):1116-28. PubMed ID: 10506694
[TBL] [Abstract][Full Text] [Related]
14. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
[TBL] [Abstract][Full Text] [Related]
15. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
Quintero E
Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
[TBL] [Abstract][Full Text] [Related]
16. Increase in screening for colorectal cancer in older Americans: results from a national survey.
Chen X; White MC; Peipins LA; Seeff LC
J Am Geriatr Soc; 2008 Aug; 56(8):1511-6. PubMed ID: 18662217
[TBL] [Abstract][Full Text] [Related]
17. [Prevention and early detection of colorectal cancer in average risk population--summary of a meeting and the Israeli gastroenterology policy].
Strul H; Elyakim R; Halpern Z; Arber N
Harefuah; 2003 Mar; 142(3):223-6, 236. PubMed ID: 12696479
[TBL] [Abstract][Full Text] [Related]
18. Risk for colorectal cancer in elderly persons and possible methodologies for their screening.
Rozen P; Shabtai EI; Liphshitz I; Barchana M
Eur J Gastroenterol Hepatol; 2011 May; 23(5):431-7. PubMed ID: 21448071
[TBL] [Abstract][Full Text] [Related]
19. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
20. Could the colonic capsule PillCam Colon be clinically useful for selecting patients who deserve a complete colonoscopy?: results of clinical comparison with colonoscopy in the perspective of colorectal cancer screening.
Gay G; Delvaux M; Frederic M; Fassler I
Am J Gastroenterol; 2010 May; 105(5):1076-86. PubMed ID: 19888198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
